<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-SEMF000017467000017XQ</udiDi>
    <basicUdiDi>B-SEMF000017467000017XQ</basicUdiDi>
    <tradeName>D-SEMF000017467000017XQ</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10270514</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:56.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000016XN</udiDi>
    <basicUdiDi>B-SEMF000017467000016XN</basicUdiDi>
    <tradeName>D-SEMF000017467000016XN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:55.635Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000015XL</udiDi>
    <basicUdiDi>B-SEMF000017467000015XL</basicUdiDi>
    <tradeName>D-SEMF000017467000015XL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312011</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:54.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000014XJ</udiDi>
    <basicUdiDi>B-SEMF000017467000014XJ</basicUdiDi>
    <tradeName>D-SEMF000017467000014XJ</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10311012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:54.304Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000013XG</udiDi>
    <basicUdiDi>B-SEMF000017467000013XG</basicUdiDi>
    <tradeName>D-SEMF000017467000013XG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:50.341Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000012XE</udiDi>
    <basicUdiDi>B-SEMF000017467000012XE</basicUdiDi>
    <tradeName>D-SEMF000017467000012XE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310011</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:49.855Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000011XC</udiDi>
    <basicUdiDi>B-SEMF000017467000011XC</basicUdiDi>
    <tradeName>D-SEMF000017467000011XC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10291012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:48.440Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000010XA</udiDi>
    <basicUdiDi>B-SEMF000017467000010XA</basicUdiDi>
    <tradeName>D-SEMF000017467000010XA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10292012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:47.637Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000009XR</udiDi>
    <basicUdiDi>B-SEMF000017467000009XR</basicUdiDi>
    <tradeName>D-SEMF000017467000009XR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10292011</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:43.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000008XP</udiDi>
    <basicUdiDi>B-SEMF000017467000008XP</basicUdiDi>
    <tradeName>D-SEMF000017467000008XP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10290012</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:42.835Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000007XM</udiDi>
    <basicUdiDi>B-SEMF000017467000007XM</basicUdiDi>
    <tradeName>D-SEMF000017467000007XM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10290011</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:42.038Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000006XK</udiDi>
    <basicUdiDi>B-SEMF000017467000006XK</basicUdiDi>
    <tradeName>D-SEMF000017467000006XK</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10271012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:41.229Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000005XH</udiDi>
    <basicUdiDi>B-SEMF000017467000005XH</basicUdiDi>
    <tradeName>D-SEMF000017467000005XH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10272012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:37.226Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000004XF</udiDi>
    <basicUdiDi>B-SEMF000017467000004XF</basicUdiDi>
    <tradeName>D-SEMF000017467000004XF</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10270012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:36.426Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000003XD</udiDi>
    <basicUdiDi>B-SEMF000017467000003XD</basicUdiDi>
    <tradeName>D-SEMF000017467000003XD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10271011</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:35.629Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000002XB</udiDi>
    <basicUdiDi>B-SEMF000017467000002XB</basicUdiDi>
    <tradeName>D-SEMF000017467000002XB</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10272011</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:34.832Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000001X9</udiDi>
    <basicUdiDi>B-SEMF000017467000001X9</basicUdiDi>
    <tradeName>D-SEMF000017467000001X9</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10270011</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:13:30.978Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-206213ME</udiDi>
    <basicUdiDi>B-206213ME</basicUdiDi>
    <tradeName>FIDIAL PLUS</tradeName>
    <deviceName>FIDIAL PLUS</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>206213</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-11T11:28:17.341Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-18906040830057PK</udiDi>
    <basicUdiDi>B-18906040830057PK</basicUdiDi>
    <tradeName>(1) Optavid Advance, (2) 1A1 AaqEye HA, (3) eyeon Hyaluronic, (4) Xailin HA, (5) Aactive HA, (6) HYALU TEARS Eye Drop</tradeName>
    <deviceName>Sodium Hyaluronate Eye Drops 0.2%w/v</deviceName>
    <manufacturerName>Amanta Healthcare Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000034912</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1220853</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-11T10:58:12.955Z</lastUpdated>
  </row>
  <row>
    <udiDi>17350030051894</udiDi>
    <basicUdiDi>B-17350030051894</basicUdiDi>
    <tradeName>Minivisc</tradeName>
    <deviceName>Minivisc Plus</deviceName>
    <manufacturerName>Bohus BioTech AB</manufacturerName>
    <manufacturerSrn>SE-MF-000037369</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-11T07:14:00.919Z</lastUpdated>
  </row>
</eudamedExport>